| 000 | 01178 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513225103.0 | ||
| 264 | 0 | _c20010103 | |
| 008 | 200101s 0 0 eng d | ||
| 022 | _a1525-4135 | ||
| 024 | 7 |
_a10.1097/00126334-200011010-00015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMurri, R | |
| 245 | 0 | 0 |
_aReduction of bronchoscopy performances should be included in the advantages of highly active antiretroviral therapy (HAART) _h[electronic resource] |
| 260 |
_bJournal of acquired immune deficiency syndromes (1999) _cNov 2000 |
||
| 300 |
_a286-7 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdiagnosis |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 |
_aBronchoscopy _xstatistics & numerical data |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aCingolani, A | |
| 700 | 1 | _aLimongelli, P | |
| 700 | 1 | _aVisconti, E | |
| 700 | 1 | _aMaiuro, G | |
| 773 | 0 |
_tJournal of acquired immune deficiency syndromes (1999) _gvol. 25 _gno. 3 _gp. 286-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00126334-200011010-00015 _zAvailable from publisher's website |
| 999 |
_c11057126 _d11057126 |
||